Cognitive Impairment 13 Months After Hospitalization for COVID-19

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2022 Aug 1

PMID 35912021

Authors

Knut Stavem

Gunnar Einvik

Christofer Lundqvist

Affiliations

Soon will be listed here.

Abstract

This study assessed cognitive function 13 months after hospital discharge for coronavirus disease 2019 (COVID-19), using computer-based cognitive tests. Compared to population norms, 14%-25% of patients were impaired in each dimension, and 53% had cognitive impairment in 1 or more of 4 tests. There was some association with acute COVID-19 disease severity.

Citing Articles

Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach.

Griffin D Open Forum Infect Dis. 2024; 11(9):ofae462.

PMID: 39220656 PMC: 11363684. DOI: 10.1093/ofid/ofae462.

References

Tansey C, Louie M, Loeb M, Gold W, Muller M, de Jager J . One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007; 167(12):1312-20. DOI: 10.1001/archinte.167.12.1312. View

Mattioli F, Stampatori C, Righetti F, Sala E, Tomasi C, De Palma G . Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol. 2021; 268(12):4422-4428. PMC: 8088203. DOI: 10.1007/s00415-021-10579-6. View

May P . Neuropsychological Outcomes in Adult Patients and Survivors of COVID-19. Pathogens. 2022; 11(4). PMC: 9025655. DOI: 10.3390/pathogens11040465. View

Mazza M, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021; 94:138-147. PMC: 7903920. DOI: 10.1016/j.bbi.2021.02.021. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Lerum T, Aalokken T, Bronstad E, Aarli B, Ikdahl E, Lund K . Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2020; 57(4). PMC: 7736755. DOI: 10.1183/13993003.03448-2020. View

Pisani M, McNicoll L, Inouye S . Cognitive impairment in the intensive care unit. Clin Chest Med. 2004; 24(4):727-37. DOI: 10.1016/s0272-5231(03)00092-3. View

Mendez R, Balanza-Martinez V, Luperdi S, Estrada I, Latorre A, Gonzalez-Jimenez P . Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med. 2021; 290(3):621-631. PMC: 8013333. DOI: 10.1111/joim.13262. View

Karlsen R, Karr J, Saksvik S, Lundervold A, Hjemdal O, Olsen A . Examining 3-month test-retest reliability and reliable change using the Cambridge Neuropsychological Test Automated Battery. Appl Neuropsychol Adult. 2020; 29(2):146-154. DOI: 10.1080/23279095.2020.1722126. View

10.

Vannorsdall T, Brigham E, Fawzy A, Raju S, Gorgone A, Pletnikova A . Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19. J Acad Consult Liaison Psychiatry. 2021; 63(2):133-143. PMC: 8591857. DOI: 10.1016/j.jaclp.2021.10.006. View

11.

Vannorsdall T, Oh E . Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: early findings and a call for further investigation. J Intern Med. 2021; 290(3):752-754. PMC: 8251291. DOI: 10.1111/joim.13271. View

12.

Dodd J, Getov S, Jones P . Cognitive function in COPD. Eur Respir J. 2010; 35(4):913-22. DOI: 10.1183/09031936.00125109. View

13.

Pandharipande P, Girard T, Jackson J, Morandi A, Thompson J, Pun B . Long-term cognitive impairment after critical illness. N Engl J Med. 2013; 369(14):1306-16. PMC: 3922401. DOI: 10.1056/NEJMoa1301372. View

14.

Torgersen J, Hole J, Kvale R, Wentzel-Larsen T, Flaatten H . Cognitive impairments after critical illness. Acta Anaesthesiol Scand. 2011; 55(9):1044-51. DOI: 10.1111/j.1399-6576.2011.02500.x. View

15.

Daroische R, Hemminghyth M, Eilertsen T, Breitve M, Chwiszczuk L . Cognitive Impairment After COVID-19-A Review on Objective Test Data. Front Neurol. 2021; 12:699582. PMC: 8357992. DOI: 10.3389/fneur.2021.699582. View

16.

Becker J, Lin J, Doernberg M, Stone K, Navis A, Festa J . Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw Open. 2021; 4(10):e2130645. PMC: 8536953. DOI: 10.1001/jamanetworkopen.2021.30645. View

17.

Beaud V, Crottaz-Herbette S, Dunet V, Vaucher J, Bernard-Valnet R, Du Pasquier R . Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry. 2020; 92(5):567-568. PMC: 8053331. DOI: 10.1136/jnnp-2020-325173. View

18.

Smith P, Need A, Cirulli E, Chiba-Falek O, Attix D . A comparison of the Cambridge Automated Neuropsychological Test Battery (CANTAB) with "traditional" neuropsychological testing instruments. J Clin Exp Neuropsychol. 2013; 35(3):319-28. DOI: 10.1080/13803395.2013.771618. View